To investigate whether the test of saliva IgA could improve the diagnostic power of COVID-19 patients, the conversion rates of saliva IgA and the detection of viral nucleic acids were analyzed in the first and second weeks after hospitalization (n = 39) (Table 4). The gene discussed is CD79A; the disease is COVID-19.